Filing metadata

Accession number
0001415889-24-024249
Form type
Form 4
Filer
Enliven Therapeutics, Inc.
CIK
CIK 1672619
Filed
Oct 01, 2024
Reporting period
Sep 27, 2024
Description
Insider transaction

Explore SEC Filings Hub